Japan’s Ministry of Health, Labor and Welfare (MHLW) on March 5 unveiled the revised NHI prices for drugs subject to…
HOME > BUSINESS
BUSINESS
- COVID-19 as Catalyst for Introducing Decentralized Clinical Trials in Japan; Some Results Due Out by Year-End
April 1, 2022
- Akebia/Otsuka’s HIF-PH Inhibitor Vadadustat Nixed in US
April 1, 2022
- Asahi Kasei Grabs Japan Rights to VectivBio’s GLP-2 Analog Peptide
April 1, 2022
- Kobayashi Kako Manufacturing Unit Now Under Sawai; 170 Staffers Remain for Compensation, Drug Handover
April 1, 2022
- Daiichi Sankyo to Offload Cravit Business in China to Local Firm
April 1, 2022
- Sumitomo Dainippon Kicks Off PI/II Study for AML Drug
April 1, 2022
- Ono Bags Global Rights to Numab’s Multispecific I/O Antibody
April 1, 2022
- Healios’ Cell Processing Center in Kobe to Begin Full Operations in Mid-2022
March 31, 2022
- Sandoz to Exclusively Sell Nichi-Iko’s Avastin Biosimilar in Japan
March 31, 2022
- Sumitomo Dainippon to Set Up Holding Firm in China
March 31, 2022
- Pfizer Files Precedex for New Pediatric Indication as “Specific Use Drug”
March 31, 2022
- Ono Collaborates with French Startup in AI-Based Drug Discovery
March 31, 2022
- Kyorin Ties Up with US Biotech for Drug Discovery Research Using Protein Engineering
March 31, 2022
- Taiho’s Biliary Cancer Med Gets US FDA’s Priority Review
March 31, 2022
- Ube, iPSC Startup to Develop IPF Drug, Eyes Clinical Trial in FY2023
March 30, 2022
- MSD Says to Ensure HPV Vaccine Supply in Japan, 4 Million-Plus Syringes for FY2022
March 30, 2022
- JCR to Focus on Partnerships as Core of Growth Strategy: Vice President
March 30, 2022
- Novartis Stepping Up Population Health Initiatives in CV, Oncology Arenas to Solve Regional Challenges
March 30, 2022
- JCR, Takeda Seal R&D Pact on Gene Therapies Using BBB Technology
March 29, 2022
- Kyowa Pharma Hit by Biz Suspension over Manufacturing Flaws, Record Fabrications
March 29, 2022
ページ
Japan is opening a new chapter in sleep medicine. The recent decision to allow medical institutions to advertise “sleep disorders”…
Let’s face it: in today’s world, changing jobs is a normal part of a successful career. But if it’s so normal, why does it feel so hard? For many people, the idea of leaving their current role brings a heavy…
Japan’s Central Social Insurance Medical Council (Chuikyo) on November 5 approved the reimbursement listing for a slate of new medicines,…
The Japanese government on March 7 announced new NHI prices to be applied in the FY2025 drug price revision, revealing…
The Japanese government approved a bill to amend the Pharmaceuticals and Medical Devices (PMD) Act at its Cabinet meeting on…
Japan’s health ministry doled out regulatory approvals for a throng of new medicines on December 27 including Eli Lilly’s obesity…
Japan’s all-important reimbursement policy panel on December 20 approved an outline of drug pricing reforms for FY2024, which enshrines a…